George Medicines announced the FDA approval of its triple therapy polypill for initial treatment of adults with hypertension.The polypill (Widaplik) — formerly known as GMRx2 — contains three ...

It’s great to see the polypill concept getting renewed impetus. And I am absolutely not being ironic here. The idea of a fire-and-forget preventive treatment containing low doses of CV-busting drugs ...

Popping a single daily pill from our 50s onwards could prevent thousands of heart attacks and strokes, according to researchers from University College London’s institute of Health Informatics.

NHS should offer ‘polypill’ to slash heart attack and stroke risk, experts claim The BMJ previously called the polypill strategy ‘one of the most important contributions to medicine in 50 ...

A single “polypill”, which combines a statin and three blood pressure -lowering drugs, could replace NHS health checks for over-fifties, according to an op-ed published in the the British ...

A polypill for preventing cardiovascular disease has the potential to address health inequities and expand health care access for low-income populations.

The polypill offers a cost-effective solution for CVD management in underserved populations, potentially reducing health disparities. The intervention is projected to cost $8560 per QALY gained ...

The recent 2023 inclusion of the polypill in the World Health Organization’s (WHO) Model List of Essential Medicines marks a landmark moment in the fight against cardiovascular diseases (CVD ...

A “polypill” could sharply reduce cardiovascular disease in the U.S. and worldwide.

Triple therapy with lipid-lowering, antihypertensive, and antiplatelet agents reduces the risk of recurrent cardiovascular fatal and nonfatal events, cardiovascular mortality, and total mortality in ...

'Polypill could avoid millions of premature deaths, heart attacks and strokes' - experts "Global health has paid a deadly price" for not using a single pill that could target blood pressure, high ...